HOME >> MEDICINE >> NEWS
New NCI grant will support Jefferson trial to study test to diagnose colorectal cancer spread

if disease spread to the lymph nodes and then follow those patients to see how they do clinically during the next five years.

"We expect to find the GCC-RT-PCR analysis will identify patients who have tiny amounts of cancer in the lymph nodes that were undetected by histopathology," he says. "The pathology will be done in parallel with testing for GCC. We believe that the patients who are histopathology negative but GCC positive will do worse in terms of clinical progression - they will develop recurrent disease that was missed the first time."

In a previous trial, Dr. Waldman and his Jefferson co-workers examined 21 colorectal cancer patients. One group of 11 patients had been disease-free for at least six years and deemed "cured." The other group of 10 patients developed recurrent disease within three years after cancer surgery. The latter had been told initially that they had no signs of cancer in their lymph nodes after surgery, meaning their cancer had not spread.

When pathologists examined lymph node samples of each patient for the presence of GCC, they found the disease-free patients' lymph nodes showed no signs of the marker. Conversely, GCC was present in every patient whose cancer had returned.

"The earlier trial was on a small scale, and until you do this [larger] trial, you really can't be sure if testing for GCC is as good as it appears," he says. "This is a prospective trial in which patients are staged and then we see how they do. In the past, the study was retrospective - we knew what happened to the patient. There's no bias in this trial - we don't know what will happen."

Dr. Waldman isn't sure that one marker will necessarily catch all colorectal cancer that has spread elsewhere in the body, noting eventually, a panel of markers may be used. "We think GCC represents an order of improvement over what is done now. Perhaps adding other markers will make it even better."

To participate in the trial, a patient must have a
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
20-Jun-2002


Page: 1 2 3 4

Related medicine news :

1. UNH launches 2nd spinout company with NIH grants
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. $4 million grant boosts University of Michigan campaign for a new childrens hospital
4. Disease testing for immigrants: Discrimination disguised as public health policy
5. NASA awards $9.8 million NSCOR grant to UT Southwestern to study effects of space radiation exposure
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. US FDA grants full approval to DOXIL(R) following submission of phase III data
8. Dartmouth awarded $21.8 million NSF grant
9. ASGE announces grant recipients in annual research awards program
10. Insulin resistance intervention after stroke focus of $33 million grant
11. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, ... Development, has been awarded a contract by the Center for Medicare and Medicaid ... to accelerate the enterprise use of Agile methodologies in a consistent and high ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the loss ... author, William Nowers. Captain Nowers and his wife, Millie, have six children, ten ... the Navy. Following his career as a naval aviator and carrier pilot, he ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... 2017 , ... The American College of Medical Informatics (ACMI) will present the ... Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual Symposium ... a pioneer in the field of medical informatics, this prestigious award is presented to ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... 2017 Diplomat Pharmacy, Inc. (NYSE: ... Consulting, LLC , and named its founder as Diplomat,s ... Tennessee , will operate under Diplomat ... service offerings for health care partners to include IT ... "In an interoperable world, technology delivers comprehensive ...
(Date:10/2/2017)... Oct. 2, 2017  AllianceRx Walgreens Prime, the combined ... Walgreens and pharmacy benefit manager Prime Therapeutics LLC (Prime), ... which included the unveiling of new signage at its ... well as at a few other company-owned facilities across ... to patients, some of whom will begin to see ...
(Date:10/2/2017)... Oct. 2, 2017 The Rebound mobile app is ... to reverse the tide of prescription drug addiction. The app ... medicine intake and stepping down their dosage in a safe, ... in December 2017; the first 100,000 people to sign up ... http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
Cached News: